Novartis
ED, Portfolio & Resource Analytics
$237K–$439K
East Hanover · Full-time · Posted Oct 27, 2026
- Experience
- Minimum 10+ years in a specified field within pharmaceutical or healthcare; minimum 5+ years of people management.
- Education
- Bachelor’s degree in Business Administration, Finance, Economics, Engineering, or a related field; an MBA or advanced degree is preferred.
About the job
Leads Novartis’ US enterprise analytics capability, shaping performance reporting, investment and resource guidance, and executive decision-making across therapeutic areas and business functions.
What you'll do
- Lead Enterprise & Functional Excellence and Enterprise Resource Optimization capability areas, setting standards for reporting, KPIs, and investment guidance.
- Own executive-level performance review processes, including Monthly Business Review, Performance Pulse, and Functional Business Reviews.
- Partner with Finance, the Office of the NVS US President, Strategy, and modeling leadership on enterprise performance and investment matters.
What they ask for
- 10+ years in enterprise analytics, business performance, resource allocation, strategic finance, or management consulting within the pharmaceutical or healthcare industry.
- 5+ years of people management experience, including leading experienced managers and building senior talent.
- Demonstrated experience establishing enterprise standards, methodologies, or reporting ecosystems adopted across a large, matrixed organization.
- Experience partnering directly with Finance leadership on performance, investment, budget, or headcount matters.
Nice to have
- Management consulting experience at a top-tier firm or comparable internal strategy leadership experience; working knowledge of the US pharmaceutical commercial model and its data and analytics ecosystem.
- Familiarity with GenAI and AI-enabled approaches to reporting, investment analysis, and process modernization.
Pay
$236,600.00 - $439,400.00 per year (base salary)
AI focus
Familiarity with GenAI and AI-enabled approaches to reporting, investment analysis, and process modernization is desirable.
Model-written summary · the original posting is authoritative